Akums demonstrates clinical versatility of Lacosamide in epilepsy care
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
The FDA is beginning rulemaking to close the “adequate provision” loophole
The payment is in accordance with the agreed contractual terms
He has been associated with the Zydus Group since 2009
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
Subscribe To Our Newsletter & Stay Updated